Forecast & Rating3 analysts currently cover Nasus Pharma, of which 2 give a positive rating. The average price target is $19.67, about 421.7% upside from the current price of $3.77. Coverage is limited, so the data is for reference only. Data as of Aug 21, 2026; this does not constitute investment advice.
Aug 21, 2026Price forecast
$19.67421.66%
Forecast & RatingBuy
2analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 2, 2026
Forecast met0.0%
Stock price$3.77
Avg. target$20.5
High target$22
Low target$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.